Assessment of cellular and humoral immunity against varicella-zoster virus in adult allogeneic hematopoietic cell transplant recipients: a cross-sectional study assessing cellular immunity after administration of an adjuvanted recombinant zoster vaccine
- 6 November 2025
- journal article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 31 (12) , 102857
Abstract
No abstract availableKeywords
Funding Information
- Government of Japan Ministry of Health Labour and Welfare (24tk0124003h0002)
- Japanese Society of Hematology
This publication has 33 references indexed in Scilit:
- Cellular and humoral immunogenicity against SARS-CoV-2 vaccination or infection is associated with the memory phenotype of T- and B-lymphocytes in adult allogeneic hematopoietic cell transplant recipientsInternational Journal of Hematology, 2024
- Long-Term Incidence of Varicella Zoster Virus Disease in Adults Receiving Single-Unit Cord Blood TransplantationTransplantation and Cellular Therapy, 2022
- Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysisThe Lancet Infectious Diseases, 2019
- Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell TransplantationJAMA, 2019
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2015
- Live Attenuated Varicella-Zoster Vaccine in Hematopoietic Stem Cell Transplantation RecipientsTransplantation and Cellular Therapy, 2014
- Vaccination of hematopoietic cell transplant recipientsBone Marrow Transplantation, 2009
- Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global PerspectiveTransplantation and Cellular Therapy, 2009
- Recovery of Varicella-Zoster Virus–Specific T Cell Immunity after T Cell–Depleted Allogeneic Transplantation Requires Symptomatic Virus ReactivationTransplantation and Cellular Therapy, 2008
- Varicella-zoster virus: Pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipientsTransplantation and Cellular Therapy, 2000